** Macquarie downgrades Australia's Ansell ANN.AX to "Neutral" rating from "Outperform", trims price target to A$31.05 from A$40.30
** The new price target represents 5.6% premium to stock's close on Tuesday
** U.S. tariffs announced on April 4 present downside for ANN, despite the company expecting to fully offset tariff impacts through pricing - Macquarie
** ANN, known for its medical gloves and surgical gowns, has ~93% of its supply chain facing U.S. reciprocal tariffs greater than 10%, Macquarie says
** Two of 10 analysts rate the stock "buy" and eight "hold"; their median PT is A$38.10 – LSEG data
** Stock down 13.1% YTD
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。